Nicholas Durham
0000-0003-1065-8474
Johns Hopkins University
2 papers found
Refreshing results…
Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus–Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
GITR ligand fusion protein agonist enhances the tumor antigen–specific CD8 T-cell response and leads to long-lasting memory
Missing publications? Search for publications with a matching author name.